BCM
RETA

Bluefin Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bluefin Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,703
Closed -$823K – 294
2020
Q1 		$823K Buy
+5,703
New +$823K 0.11% 87
2019
Q4 		– Hold
0
– – – 478